NCT03307785 2025-11-25Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042Tesaro, Inc.Phase 1 Completed60 enrolled 91 charts
NCT03739710 2025-06-15Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)GlaxoSmithKlinePhase 2 Completed175 enrolled 5 charts